Source: EIN Presswire

Press Release: Vidac Pharma : Vidac Pharma to Present Possible Cooperation with Johnson & Johnson at Basel Launch's 'Beyond the Needle' Event

Vidac Pharma (XSTU:Hamburg and Stuttgart: T9G; ISIN: GB00BM9XQ619; WKN: A3DTUQ) LONDON, UNITED KINGDOM, October 23, 2025 /⁨EINPresswire.com⁩/ -- Vidac Pharma Holdings Plc. a clinical-stage oncology company pioneering first-in-class therapies targeting the ...

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Oren M. Becker's photo - President & CEO of Vidac Pharma

President & CEO

Oren M. Becker

CEO Approval Rating

69/100

Read more